Consumer Feels Like...
Health Care: Drugs
Acorda Therapeutics Inc. (ACOR: NASDAQ)
$25.57 -0.84 | -3.18%
02/09/12 - 01:45 PM ET
227.73K / 498.40K
Vol / Avg. Vol:26.38 / 26.41
Open / Prev. Close:25.44 - 26.52
Today's Range:18.36 - 33.48
52 Wk Range:10.78%
Performance YTD:TheStreet Rating:
Portfolios with ACOR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor13 Biotech Stocks Bought an...
- Contributor5 Biotech Drug-Launch Stock...
- Usergrandpicks
- UserPART 1 JPMorgan 28th Annual...
- ProTurner Emerging Growth TMCGX
- ContributorBarron's Research Reports 3...
- UserUndervalued Biotech's
- UserPART 1 JPMorgan 27th Annual...
Latest ACOR Headlines from TheStreet
- 8 Stocks Rising on Huge Volume 01.05.12 | 02:01 pm
- Acorda Rises On Unusually High Volume (ACOR) 11.04.11 | 04:11 pm
- Acorda Stock Hits New 52-Week Low (ACOR) 09.29.11 | 01:09 pm
- SAC Upped Dendreon Exposure Before Blowup 08.15.11 | 05:08 pm
- 5 Biotech Drug-Launch Stocks to Watch 07.18.11 | 09:07 am
- Acorda Stock Gaps Up On Today's Open (ACOR) 05.20.11 | 09:05 am
- European Regulators Approve New Drugs 05.20.11 | 07:05 am
- 5 Stocks to Watch: LinkedIn, Barnes & Noble 05.20.11 | 07:05 am
- Acorda Therapeutics Inc. Stock Upgraded (ACOR) 05.09.11 | 08:05 am
- Alkermes to Buy Elan Unit for $960M 05.09.11 | 07:05 am
Press Releases for ACOR
- Acorda Therapeutics To Present At Leerink Swann 2012 Global Healthcare Conference - Business Wire 02.09.12 | 06:02 am
- Acorda Therapeutics To Host Conference Call To Discuss Fourth Quarter And Full Year 2011 Financial Results On February 16, 2012 - Business Wire 02.09.12 | 06:02 am
- Acorda Therapeutics To Present At 14th Annual BIO CEO & Investor Conference - Business Wire 02.07.12 | 06:02 am
- Acorda Therapeutics Announces Launch Of Authorized Generic Version Of ZANAFLEX CAPSULES® - Business Wire 02.06.12 | 04:02 pm
- Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function In Chronic Stroke - Business Wire 02.03.12 | 07:02 am
- Acorda Therapeutics Provides 2012 Corporate Update At 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.09.12 | 06:01 am
- Acorda Therapeutics To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 12.28.11 | 06:12 am
- Acorda Therapeutics To Present At The Piper Jaffray 23rd Annual Healthcare Conference - Business Wire 11.22.11 | 06:11 am
- Acorda Therapeutics Announces Preclinical Data On GGF2 In Heart Failure Presented At American Heart Association Scientific Sessions 2011 - Business Wire 11.16.11 | 07:11 am
- Acorda Therapeutics To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - Business Wire 11.08.11 | 06:11 am
Partner Headlines for ACOR
- 5 Stocks Ripe For A Takeover - Seeking Alpha 10.28.11 | 05:10 pm
- Notable Call Options Activity in Acorda Therapeutics - Benzinga 10.13.11 | 01:10 pm
- Company News for October 6, 2011 - Corporate Summary - Zacks 10.06.11 | 10:10 am
- 7 Possible Biotech Takeover Targets - Seeking Alpha 09.18.11 | 08:09 am
- 5 Biotech Takeover / LBO Targets With Bullish Short Trends - Seeking Alpha 07.15.11 | 07:07 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 07.12.11 | 09:07 am
- Acorda Therapeutics Jumping On Takeover Rumors - Benzinga 06.07.11 | 01:06 pm
- 7 Dirt-Cheap Takeover Targets in Biotech - Seeking Alpha 06.03.11 | 09:06 am
- CHMP Backs Biogen's Fampyra - Analyst Blog - Zacks 05.23.11 | 06:05 pm
- CHMP Backs Biogen's Fampyra - Analyst Blog - Zacks 05.23.11 | 06:05 pm
